Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06088810 · ClinicalTrials.gov registry record · NA

The Impact of Music Intervention on Sleep

A NA study, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
144
Enrollment target

NCT06088810: Recruiting NA study, sponsored by Duke University.

NCT06088810 is a NA study that is actively recruiting participants, run by Duke University. The registered enrollment target is 144 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06088810, a NA study, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target

Study Summary

The primary purpose of this Stage 1b NIH-funded clinical trial (K23AG073618, PI Petrovsky) is to determine the efficacy of a 1-month music intervention (Calming Music Personalized for Sleep Enhancement in PeRsons living with Dementia, CoMPoSER) on health outcomes in 72 dyads (144 participants) of persons living with dementia (PLWD) and their caregivers (Stage 1b). The secondary purpose of this research project is to examine the mechanism of stress reduction and sustained effects of the music intervention on PLWD and caregiver well-being. We will evaluate the acceptability of the mobile application CoMPoSER in a pilot RCT and determine the impact of the mobile application CoMPoSER on PLWD (sleep latency, sleep efficiency, wake after sleep onset, total sleep time, sleep quality) and caregiver (perceived stress and well-being) outcomes.

Primary Outcome

At least 80% of the dyads will find the intervention acceptable

Interventions

  • OTHER CoMPoSER intervention group
  • OTHER Sleep Education

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2026-04-03
Est. Completion 2026-08-31
Phase NA
Duke University

1,725 total trials

What NCT06088810 shows while recruiting

NCT06088810 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which CoMPoSER intervention group is the first listed.

NCT06088810 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06088810 about?

NCT06088810 is a clinical study titled "The Impact of Music Intervention on Sleep". The primary purpose of this Stage 1b NIH-funded clinical trial (K23AG073618, PI Petrovsky) is to determine the efficacy of a 1-month music intervention (Calming Music Personalized for Sleep Enhancement in PeRsons living with Dementia, CoMPoSER) on health outcomes in 72 dyads (144 participants) of pe...

What is the current status of trial NCT06088810?

This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2026-04-03. Estimated completion is 2026-08-31.

What interventions are being tested in trial NCT06088810?

The interventions under investigation include: CoMPoSER intervention group (OTHER), Sleep Education (OTHER).

Who is sponsoring clinical trial NCT06088810?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06088810's enrollment target sits among peer trials

144 706th of 2000 higher than 1,290 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06088810, the US trial registry maintained by the National Library of Medicine. NCT06088810 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.